Manchester Metropolitan University

- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1970-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.mmu.ac.uk
Clinical Trials
24
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Heat Therapy and Peripheral Artery Disease
- Conditions
- Peripheral Arterial DiseaseCardiovascular HealthVascular FunctionPeripheral Vascular DiseasesIntermittent Claudication
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Manchester Metropolitan University
- Target Recruit Count
- 70
- Registration Number
- NCT06827691
- Locations
- 🇬🇧
Manchester Metropolitan University, Manchester, United Kingdom
Driving with Neuropathy
- Conditions
- Diabetic PolyneuropathyDiabetes Mellitus, Type 2
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Manchester Metropolitan University
- Target Recruit Count
- 115
- Registration Number
- NCT06739135
- Locations
- 🇬🇧
Manchester Metropolitan University, Manchester, United Kingdom
Prehabilitation's Effect on Skeletal Muscle Mass in Cardiac Patients
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Manchester Metropolitan University
- Target Recruit Count
- 30
- Registration Number
- NCT06624774
- Locations
- 🇬🇧
Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom
Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Manchester Metropolitan University
- Target Recruit Count
- 15
- Registration Number
- NCT06063733
- Locations
- 🇨🇳
The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
Determinants of Progression From Phase III to IV Cardiac Rehabilitation
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Manchester Metropolitan University
- Target Recruit Count
- 90
- Registration Number
- NCT05784272
- Locations
- 🇬🇧
Aneurin Bevan University Hospital, Caerleon, Gwent, United Kingdom
🇬🇧Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
🇬🇧Stockport NHS Foundation Trust, Stockport, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- Next